Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas.
Mazzaro
Cesare
C
De Re
Valli
V
Spina
Michele
M
Dal Maso
Luigino
L
Festini
Gianluca
G
Comar
Consuelo
C
Tirelli
Umberto
U
Pozzato
Gabriele
G
D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000821:virology; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a